Dose-response and efficacy of ferric citrate to treat hyperphosphatemia in hemodialysis patients: a short-term randomized trial.

Dwyer JP, Sika M, Schulman G, Chang IJ, Anger M, Smith M, Kaplan M, Zeig S, Koury MJ, Blumenthal SS, Lewis JB, Collaborative Study Group
Am J Kidney Dis. 2013 61 (5): 759-66

PMID: 23369827 · DOI:10.1053/j.ajkd.2012.11.041

MeSH Terms (16)

Administration, Oral Dose-Response Relationship, Drug Female Ferric Compounds Follow-Up Studies Hematinics Humans Hyperphosphatemia Kidney Failure, Chronic Male Middle Aged Phosphorus Prospective Studies Renal Dialysis Time Factors Treatment Outcome

Connections (3)

This publication is referenced by other Labnodes entities:

Links